Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Camp Therapeutics identifies new antibacterial peptides

Oct. 29, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents HBV HBsAg secretion inhibitors

Oct. 29, 2021

Chemoattractant attachment boosts antibiotic efficacy

Oct. 28, 2021

Novel anti-inflammatory agent significantly improves LPS-induced sepsis in vivo

Oct. 28, 2021

RFN-ALFQ nanoparticle vaccine elicits immunity against SARS-CoV-2 in macaques

Oct. 27, 2021

Thomas Jefferson University, Context Therapeutics patent androgen and SIGMAR1 receptor antagonists

Oct. 26, 2021

Janssen BioPharma presents compounds for inhibiting respiratory syncytial virus replication

Oct. 26, 2021

New human SARS-CoV-2 vaccines based on AAV vectors presented

Oct. 26, 2021

Monash University divulges antibiotic peptide-drug conjugates

Oct. 25, 2021

Ligand grants CRDC Asian rights to develop COVID-19 antiviral using BEPro technology

Oct. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...